Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 276 trials across Europe, recruiting first
Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer
BelgiumStudy of Relatlimab and Nivolumab with Chemotherapy for Patients with Stage IV or Recurrent Non-Small Cell Lung Cancer
BelgiumStudy of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Not Had Chemotherapy
FranceStudy of BMS-986012 with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer
SpainStudy on the Effect of Dupilumab for Patients with Chronic Rhinosinusitis with Nasal Polyps
AustriaStudy on the Effects of Amikacin Liposome Inhalation, Azithromycin, and Ethambutol in Adults with Newly Diagnosed Nontuberculous Mycobacterial Lung Infection
AustriaStudy on Dronabinol for Reducing Severe Breathlessness in Patients with Severe and Very Severe Chronic Obstructive Pulmonary Disease (COPD)
DenmarkStudy on the Effects of Mepolizumab for Achieving Clinical Remission in Patients with Severe Asthma
BelgiumStudy of Osimertinib and Chemotherapy for Patients with EGFR Mutation Positive Resectable Non-Small Cell Lung Cancer
AustriaStudy on the Safety and Effectiveness of Nirmatrelvir and Ritonavir for Nonhospitalized Children with COVID-19 at Risk of Severe Illness
BulgariaStudy Comparing Selpercatinib with a Drug Combination for Patients with Advanced RET Fusion-Positive Non-Small Cell Lung Cancer
BelgiumStudy on the Effects of Itepekimab on Airway Inflammation in Former Smokers with Chronic Obstructive Pulmonary Disease (COPD)
BelgiumThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
